Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
- PMID: 34083026
- PMCID: PMC8165560
- DOI: 10.1016/j.therap.2021.05.007
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
Keywords: Anti-PF4 antibodies; Atypical thrombosis; Covid-19 vaccine; Pharmacovigilance; Thrombopenia; VaxZevria®.
Comment on
-
French Pharmacovigilance Public System and COVID-19 Pandemic.Drug Saf. 2021 Apr;44(4):405-408. doi: 10.1007/s40264-020-01034-y. Epub 2020 Dec 28. Drug Saf. 2021. PMID: 33372244 Free PMC article.
References
-
- European Medicines Agency. AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low platelets. 7 April 2021. https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-find.... [Accessed 17 May 2021].
-
- British Society for Haematology. Guidance produced from the Expert Haematology Panel (EHP) focussed on syndrome of thrombosis and thrombocytopenia occurring after coronavirus vaccination. 26 April 2021. https://b-s-h.org.uk/media/19512/guidance-version-10-on-mngmt-of-thrombo.... [Accessed 17 May 2021 (4 pp.)].
-
- GEMMAT - Groupe d’étude multidisciplinaire en maladie thrombotique. VIPIT: thromboses post-vaccination COVID19. 16 April 2021. https://www.gemmat-thrombose.fr/vipit-thromboses-post-vaccination-covid19/. [Accessed 17 May 2021].
-
- Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 doi: 10.1056/NEJMoa2104840. https://www.nejm.org/doi/10.1056/NEJMoa2104840?url_ver=Z39.88-2003&r.... [Accessed 17 May 2021] - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
